495 related articles for article (PubMed ID: 24711000)
1. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
[TBL] [Abstract][Full Text] [Related]
2. Urine neutrophil gelatinase associated lipocalin as an early marker of acute kidney injury in hematopoietic stem cell transplantation patients.
Taghizadeh-Ghehi M; Sarayani A; Ashouri A; Ataei S; Moslehi A; Hadjibabaie M
Ren Fail; 2015 Jul; 37(6):994-8. PubMed ID: 25945602
[TBL] [Abstract][Full Text] [Related]
3. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass.
Song JW; Shim JK; Soh S; Jang J; Kwak YL
Nephrology (Carlton); 2015 Feb; 20(2):96-102. PubMed ID: 25384603
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation.
Hilmi IA; Peng Z; Planinsic RM; Damian D; Dai F; Tyurina YY; Kagan VE; Kellum JA
Nephrol Dial Transplant; 2010 Jul; 25(7):2328-33. PubMed ID: 20179007
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine decreases urinary level of neutrophil gelatinase-associated lipocalin in deceased-donor renal transplant recipients: a randomized clinical trial.
Modarresi A; Nafar M; Sahraei Z; Salamzadeh J; Chaibakhsh S; Ziaie S; Parvin M; Panahi Y; Einollahi B
Biomarkers; 2018 Sep; 23(6):589-596. PubMed ID: 29683755
[TBL] [Abstract][Full Text] [Related]
7. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial.
Moslehi A; Taghizadeh-Ghehi M; Gholami K; Hadjibabaie M; Jahangard-Rafsanjani Z; Sarayani A; Javadi M; Esfandbod M; Ghavamzadeh A
Bone Marrow Transplant; 2014 Jun; 49(6):818-23. PubMed ID: 24614837
[TBL] [Abstract][Full Text] [Related]
9. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
[TBL] [Abstract][Full Text] [Related]
12. Use of N-acetylcysteine during liver procurement: a prospective randomized controlled study.
D'Amico F; Vitale A; Piovan D; Bertacco A; Ramirez Morales R; Chiara Frigo A; Bassi D; Bonsignore P; Gringeri E; Valmasoni M; Garbo G; Lodo E; D'Amico FE; Scopelliti M; Carraro A; Gambato M; Brolese A; Zanus G; Neri D; Cillo U
Liver Transpl; 2013 Feb; 19(2):135-44. PubMed ID: 22859317
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the RIFLE criteria for acute kidney injury after myeloablative allogeneic haematopoietic stem cell transplantation.
Bao YS; Xie RJ; Wang M; Feng SZ; Han MZ
Swiss Med Wkly; 2011; 141():w13225. PubMed ID: 21769755
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.
Fraga CM; Tomasi CD; Damasio DC; Vuolo F; Ritter C; Dal-Pizzol F
Crit Care; 2016 Oct; 20(1):331. PubMed ID: 27745551
[TBL] [Abstract][Full Text] [Related]
15. Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation.
Abramson MH; Gutgarts V; Zheng J; Maloy MA; Ruiz JD; Scordo M; Jaimes EA; Sathick IJ
Clin J Am Soc Nephrol; 2021 Sep; 16(9):1318-1327. PubMed ID: 34135023
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine (NAC) protects against acute kidney injury (AKI) following prolonged pneumoperitoneum in the rat.
Seguro AC; Poli de Figueiredo LF; Shimizu MH
J Surg Res; 2012 Jun; 175(2):312-5. PubMed ID: 21764077
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation.
Kagoya Y; Kataoka K; Nannya Y; Kurokawa M
Biol Blood Marrow Transplant; 2011 Mar; 17(3):394-400. PubMed ID: 20655388
[TBL] [Abstract][Full Text] [Related]
18. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial.
Kandil MA; Abouelenain KM; Alsebaey A; Rashed HS; Afifi MH; Mahmoud MA; Yassen KA
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28564127
[TBL] [Abstract][Full Text] [Related]
19. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis.
Siriwardena AK; Mason JM; Balachandra S; Bagul A; Galloway S; Formela L; Hardman JG; Jamdar S
Gut; 2007 Oct; 56(10):1439-44. PubMed ID: 17356040
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial.
Hynninen MS; Niemi TT; Pöyhiä R; Raininko EI; Salmenperä MT; Lepäntalo MJ; Railo MJ; Tallgren MK
Anesth Analg; 2006 Jun; 102(6):1638-45. PubMed ID: 16717300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
